TXG
10x Genomics, Inc.
Health Information Services · Healthcare · United States
81.55
close · 2026-10-29
value
1
cheaper than peers1
quality
14
stronger fundamentals14
ranked against
Health Information Services
value
quality
27 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 12.05× | 13 |
| price to book | 12.87× | 10 |
| forward P/E | 1063.65× | 2 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 9.5% | 69 |
| return on equity | -9.4% | 40 |
| operating margin | -15.2% | 17 |
| revenue growth | -12.7% | 4 |
4 of 4 measures available
Facts
| market cap | $11B |
| free cash flow | $179.7M |
| employees | 1,178 |
| first trade | 2019-09-12 |
| next earnings | 2026-11-05 |
| fundamentals updated | 2026-08-10 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -0.35 | -1.52 | -2.18 | -1.46 |
| free cash flow | $130.1M | -$6.7M | -$64.7M | -$165.3M |
| net income | -$43.5M | -$182.6M | -$255.1M | -$166.0M |
| revenue | $642.8M | $610.8M | $618.7M | $516.4M |
| unusual items | $49.9M | $0 | -$61.0M | $0 |